This company listing is no longer active
FSQA Stock Overview
AlerisLife Inc. operates and manages senior living communities in the United States. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
AlerisLife Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$1.21 |
52 Week High | US$2.18 |
52 Week Low | US$0.51 |
Beta | 0.96 |
11 Month Change | 0.83% |
3 Month Change | 77.94% |
1 Year Change | -40.10% |
33 Year Change | -47.84% |
5 Year Change | -88.25% |
Change since IPO | -96.64% |
Recent News & Updates
Recent updates
Shareholder Returns
FSQA | DE Healthcare | DE Market | |
---|---|---|---|
7D | 0.8% | 0.1% | -0.02% |
1Y | -40.1% | 17.2% | 8.2% |
Return vs Industry: FSQA underperformed the German Healthcare industry which returned -28.6% over the past year.
Return vs Market: FSQA underperformed the German Market which returned -13.8% over the past year.
Price Volatility
FSQA volatility | |
---|---|
FSQA Average Weekly Movement | 20.9% |
Healthcare Industry Average Movement | 4.1% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.9% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: FSQA's share price has been volatile over the past 3 months.
Volatility Over Time: FSQA's weekly volatility has increased from 14% to 21% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | 8,600 | Jeff Leer | www.alerislife.com |
AlerisLife Inc. operates and manages senior living communities in the United States. It operates through two segments, Residential and Lifestyle Services. Its senior living communities comprise independent living communities, assisted living communities, memory care, continuing care retirement communities (CCRCs), skilled nursing facilities (SNFs), and an active adult community.
AlerisLife Inc. Fundamentals Summary
FSQA fundamental statistics | |
---|---|
Market cap | €41.18m |
Earnings (TTM) | -€35.24m |
Revenue (TTM) | €148.96m |
0.3x
P/S Ratio-1.2x
P/E RatioIs FSQA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
FSQA income statement (TTM) | |
---|---|
Revenue | US$159.70m |
Cost of Revenue | US$90.05m |
Gross Profit | US$69.65m |
Other Expenses | US$107.43m |
Earnings | -US$37.78m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -1.13 |
Gross Margin | 43.61% |
Net Profit Margin | -23.66% |
Debt/Equity Ratio | 43.8% |
How did FSQA perform over the long term?
See historical performance and comparison